Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Open-label Extension Trial for Pre- and Postmenopausal Women With HSDD
Brief Summary: To generate additional long-term safety and efficacy data on flibanserin in premenopausal women and establish long-term safety and tolerability of flibanserin in naturally postmenopausal women with Hypoactive Sexual Desire Disorder who have completed a prior clinical trial of flibanserin (Trial 511.130, 511.147, or 511.156).